Sorrento Therapeutics, Inc. Vickers Vantage Corp. I (VCKA) insider trading activity

Sorrento Therapeutics, Inc. is > 10% Shareholder of Vickers Vantage Corp. I. Currently has a direct ownership of 1.92 Million shares of VCKA, which is worth approximately $0. The most recent transaction as insider was on Sep 21, 2023, when has been sold 60,068,585 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.92M

0% 3M change

0% 12M change

Total Value Held $0

Sorrento Therapeutics, Inc. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Sep 21 2023	SELL Open market or private sale	-	60,068,585 Reduced 96.91%	1,917,210 Common Stock
Jan 19 2023	SELL Other acquisition or disposition	-	73,740,795 Reduced 54.33%	61,985,795 Common Stock

Also insider at

CELU

Celularity Inc Healthcare

> 10% Shareholder

STI